CX3CL1 and Miyoshi myopathy: On the other hand, any significant correlation was not observed between the BM CX3CL1 plasma levels with the presence of osteolytic lesions (P = 0.34, not significant NS, Supplemental Figure S1A) or the presence of high bone disease (HBD) compared to low bone disease (LBD) (P = 0.78, NS) in MM patients (Supplemental Figure S1B).